+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aquaculture Vaccines Market - Global Forecast 2026-2032- Product Image
Aquaculture Vaccines Market - Global Forecast 2026-2032- Product Image
Sale

Aquaculture Vaccines Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715887
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Aquaculture Vaccines Market is projected to reach USD 410.74 Million in 2026. It is expected to continue growing at a CAGR of 4.94%, reaching USD 547.65 Million by 2032.

Aquaculture vaccines are becoming central to sustainable fish and shrimp farming as producers seek to reduce mortality, improve animal welfare, and limit reliance on antibiotics. Disease outbreaks remain one of the most persistent constraints in aquaculture, affecting salmonids, tilapia, carp, catfish, seabass, seabream, shrimp, and other commercially farmed species. Vaccination supports preventive aquatic animal health management by stimulating immunity against bacterial, viral, and parasitic pathogens through injectable, immersion, oral, and emerging mucosal delivery formats. Demand is being shaped by stricter antimicrobial stewardship policies, expansion of intensive aquaculture systems, rising seafood consumption, and greater scrutiny of biosecurity across hatcheries, nurseries, grow-out farms, and processing supply chains. The aquaculture vaccines landscape is also evolving alongside genomics, adjuvant science, recombinant platforms, DNA vaccines, inactivated vaccines, live attenuated vaccines, and autogenous solutions tailored to regional pathogen profiles. For industry stakeholders, the strategic priority is shifting from reactive disease treatment to integrated prevention programs that combine vaccination, diagnostics, nutrition, water-quality management, and traceable health records.

Transformative Shifts in the Aquaculture Vaccine Landscape

The aquaculture vaccines landscape is undergoing a structural shift from broad disease control toward precision health management. Farmers are increasingly aligning vaccination schedules with species biology, production stage, water temperature, pathogen seasonality, and stress events such as transfer, grading, and stocking density changes. Injectable vaccines remain important in high-value finfish segments where individual handling is feasible, while oral and immersion vaccines are gaining attention for early-life-stage protection and mass administration in species where handling costs and stress are limiting factors. Regulatory pressure to curb antimicrobial use is strengthening the role of preventive immunization, especially as seafood buyers and retailers emphasize responsible sourcing and residue-free production. Another major transformation is the growing use of pathogen surveillance and molecular diagnostics to identify circulating strains before vaccine selection. The field is also moving toward multivalent vaccines that address several pathogens in a single program, reducing labor intensity and improving compliance. As farming systems become more intensive and geographically interconnected, vaccine strategies are increasingly being integrated with biosecurity protocols, broodstock health certification, hatchery sanitation, and digital farm management platforms.

Cumulative Impact of Artificial Intelligence on Aquaculture Vaccines

Artificial intelligence is adding measurable value to aquaculture vaccine development, disease surveillance, and farm-level decision-making. AI-enabled bioinformatics can accelerate antigen discovery by screening pathogen genomes and identifying immunogenic candidates for recombinant, subunit, and DNA vaccine design. Machine learning models are also being used to analyze water-quality data, feeding behavior, mortality patterns, temperature shifts, and diagnostic results to predict disease risk and support timely vaccination or booster decisions. In production settings, AI-supported image analytics and sensor networks can detect abnormal swimming, lesions, or appetite changes before visible outbreak escalation, helping farmers improve vaccine timing and evaluate field effectiveness. AI can further strengthen pharmacovigilance by organizing post-vaccination performance data, adverse-event observations, and survival outcomes across species and farming environments. However, the cumulative impact of artificial intelligence depends on high-quality datasets, standardized health records, responsible data governance, and validation under real aquaculture conditions. The most effective applications are likely to combine AI with veterinary expertise, laboratory diagnostics, epidemiology, and practical knowledge of local husbandry systems.

Key Regional Insights for Aquaculture Vaccines

Asia-Pacific remains the most diverse aquaculture vaccines region because it contains major warm-water aquaculture systems for carp, tilapia, shrimp, pangasius, seabass, and marine finfish, alongside expanding interest in vaccination as producers respond to bacterial and viral disease pressures and antibiotic reduction goals. North America is characterized by strong regulatory oversight, advanced aquatic veterinary services, and established vaccination practices in salmonid production, with growing attention to recirculating aquaculture systems and biosecure hatchery models. Latin America is an important aquaculture health region due to large-scale salmon farming in the south and tilapia and shrimp production across tropical and subtropical areas, creating demand for vaccines aligned with regional pathogens and changing environmental conditions. Europe has a mature preventive fish health framework supported by stringent animal welfare, food safety, and antimicrobial-resistance policies, making vaccination a core component of salmon, trout, seabass, and seabream health programs. The Middle East is increasingly focused on aquaculture development for food security, particularly marine finfish and shrimp farming in arid environments, where vaccination must be paired with controlled water systems and biosecurity. Africa presents a rising opportunity for aquaculture vaccines as tilapia and catfish farming expands, yet adoption depends on affordability, cold-chain access, veterinary capacity, farmer training, and vaccine formats suitable for small and medium-scale producers.

Key Group Insights for Aquaculture Vaccines

ASEAN countries are central to tropical aquaculture vaccine relevance because of intensive shrimp, tilapia, pangasius, and marine fish farming, where disease prevention must account for fragmented production systems, hatchery quality, and cross-border aquatic animal trade. The GCC is increasingly positioning aquaculture as part of food security strategy, and vaccine adoption in this group is closely linked to controlled marine farming, recirculating systems, and efforts to manage disease under high-temperature and high-salinity conditions. The European Union provides one of the strongest policy environments for aquaculture vaccines through coordinated attention to antimicrobial reduction, animal health law, welfare standards, and sustainable seafood production. BRICS countries collectively represent a broad spectrum of aquaculture systems, including large freshwater production, marine finfish farming, and emerging high-technology facilities, making vaccine demand highly species-specific and dependent on national regulatory pathways and veterinary infrastructure. G7 countries generally show higher integration of diagnostics, traceability, research capacity, and regulatory compliance in aquatic animal health programs, supporting advanced vaccine development and post-approval monitoring. NATO member countries overlap significantly with advanced regulatory and biosecurity frameworks in North America and Europe, where aquaculture vaccine strategies are often shaped by food safety, supply chain resilience, and antimicrobial stewardship objectives.

Key Country Insights for Aquaculture Vaccines

The United States is advancing aquaculture vaccines through a combination of biosecure hatchery practices, aquatic animal health oversight, and rising interest in recirculating aquaculture systems for salmonids, marine finfish, and emerging species. Canada has an established vaccination culture in salmon aquaculture, supported by veterinary programs that emphasize bacterial disease prevention, sea-transfer health planning, and environmental monitoring. Mexico is relevant for tilapia, shrimp, and marine aquaculture, where vaccine adoption is influenced by disease surveillance capacity and the need to reduce production losses in warm-water systems. Brazil’s large freshwater aquaculture base, particularly tilapia, supports growing interest in preventive health tools, while regional disease variability creates demand for practical and scalable vaccination approaches. The United Kingdom maintains a sophisticated aquatic animal health environment linked to salmon farming, regulatory oversight, and welfare-driven production standards. Germany and France contribute through strong veterinary science, biotechnology capabilities, and EU-aligned regulatory frameworks, while Russia’s aquaculture vaccine needs are tied to cold-water and freshwater species development across varied climatic zones. Italy and Spain are important Mediterranean aquaculture countries where seabass, seabream, trout, and shellfish-related health management support continued emphasis on preventive disease control. China has the world’s largest aquaculture production base, making vaccine relevance highly significant across freshwater fish, marine finfish, and shrimp systems, although implementation varies by species, farm scale, and regional veterinary infrastructure. India’s aquaculture vaccine potential is shaped by shrimp, carp, and tilapia production, with priorities around hatchery biosecurity, disease diagnostics, and farmer-accessible delivery methods. Japan combines advanced aquatic health science with high-value marine and freshwater species, supporting targeted vaccine use and technology development. Australia emphasizes biosecurity, aquatic animal health regulation, and high-value aquaculture species, while South Korea’s marine finfish, flatfish, and shellfish sectors support demand for vaccination strategies integrated with diagnostics and farm management.

Actionable Recommendations for Aquaculture Vaccine Leaders

Industry leaders should prioritize vaccine strategies that are species-specific, pathogen-specific, and aligned with real farm conditions rather than adopting standardized protocols without local validation. Producers should invest in routine diagnostics, pathogen strain mapping, and health record systems to guide vaccine selection and measure performance after administration. Vaccine developers should focus on delivery innovation, including oral and immersion technologies that reduce handling stress and improve scalability for small fish, shrimp, and high-volume species. Regulators and industry associations can strengthen adoption by improving approval clarity, supporting post-vaccination monitoring, and promoting science-based antimicrobial stewardship. Hatcheries should be treated as critical control points because early-life-stage health, broodstock screening, and biosecure seed movement directly influence disease outcomes downstream. Feed, genetics, diagnostics, and veterinary service providers should collaborate on integrated health programs that combine vaccination with nutrition, selective breeding for disease resistance, water-quality control, and farm staff training. Leaders should also build contingency plans for emerging pathogens by maintaining surveillance networks, regional data-sharing mechanisms, and flexible vaccine development pathways, including autogenous or strain-matched approaches where permitted.

Research Methodology

This executive summary is developed from a structured secondary research approach focused on verified public and industry-relevant evidence, including aquatic animal health guidelines, food safety and antimicrobial-resistance policy documents, peer-reviewed scientific literature, regulatory references, aquaculture production reports, veterinary research publications, and disease surveillance resources. The methodology emphasizes triangulation across multiple credible sources to identify consistent trends in vaccine technologies, species applications, pathogen priorities, regulatory drivers, and regional adoption factors. Insights were assessed qualitatively without using market sizing, market share, estimation, or forecasting. The research framework considered vaccine type, route of administration, farmed species, disease category, production environment, geographic policy context, and adoption barriers such as cost, cold chain, handling stress, veterinary access, and regulatory requirements. AI-related insights were evaluated through documented applications in bioinformatics, disease prediction, image analytics, sensor-based monitoring, and decision support, with attention to validation and data-quality limitations. Regional, group, and country insights were synthesized into narrative findings to support search visibility while maintaining evidence-based relevance for aquaculture health stakeholders.

Conclusion

Aquaculture vaccines are increasingly essential to resilient seafood production as the sector balances disease pressure, antimicrobial stewardship, animal welfare, and sustainable intensification. The strongest opportunities lie in integrated health programs that combine vaccination with diagnostics, biosecurity, environmental monitoring, genetics, nutrition, and data-driven decision-making. Regional priorities vary significantly: mature salmonid and Mediterranean systems emphasize advanced preventive protocols, while tropical freshwater and shrimp-producing regions require scalable, affordable, and field-ready vaccine solutions. Artificial intelligence, genomics, and improved delivery platforms are expected to enhance vaccine discovery, disease prediction, and farm-level performance monitoring, provided they are supported by robust data and veterinary oversight. For decision-makers, the path forward is clear: prevention-led aquatic animal health strategies can reduce outbreak risk, strengthen responsible production, and support more reliable seafood supply chains without relying on unsustainable antimicrobial use.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Aquaculture Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. DNA
7.3. Inactivated
7.4. Live Attenuated
7.5. Recombinant
7.6. Subunit
8. Aquaculture Vaccines Market, by Route Of Administration
8.1. Introduction
8.2. Immersion
8.2.1. Bath
8.2.2. Dip
8.3. Injection
8.4. Oral
9. Aquaculture Vaccines Market, by Target Species
9.1. Introduction
9.2. Finfish
9.2.1. Carp
9.2.2. Catfish
9.2.3. Salmon
9.2.4. Tilapia
9.2.5. Trout
9.3. Shellfish
9.3.1. Crab
9.3.2. Mussel
9.3.3. Oyster
9.3.4. Shrimp
10. Aquaculture Vaccines Market, by Technology Platform
10.1. Introduction
10.2. Conventional
10.3. Next Generation
11. Aquaculture Vaccines Market, by Pathogen Type
11.1. Introduction
11.2. Bacterial
11.3. Fungal
11.4. Parasitic
11.5. Viral
12. Aquaculture Vaccines Market, by Application
12.1. Introduction
12.2. Prophylactic
12.3. Therapeutic
13. Aquaculture Vaccines Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Aquaculture Vaccines Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Aquaculture Vaccines Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Benchmark Holdings plc
17.2. Bio Angle Vacs Sdn Bhd
17.3. Ceva Sante Animale
17.4. Hester Biosciences Limited
17.5. HIPRA S A
17.6. Ictyogroup
17.7. Indian Immunologicals Ltd
17.8. KBNP Inc
17.9. Kyoto Biken Laboratories Inc
17.10. Merck & Co Inc
17.11. Nisseiken Co Ltd
17.12. Phibro Animal Health Corporation
17.13. Tecnovax S A
17.14. Vaxxinova International B V by EW Group
17.15. Veterquimica S A
17.16. Virbac S A
17.17. Zoetis Inc
List of Figures
FIGURE 1. GLOBAL AQUACULTURE VACCINES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL AQUACULTURE VACCINES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL AQUACULTURE VACCINES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL AQUACULTURE VACCINES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL AQUACULTURE VACCINES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2025 VS 2032 (%)
FIGURE 11. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2032 (%)
FIGURE 13. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL AQUACULTURE VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL AQUACULTURE VACCINES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL AQUACULTURE VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DNA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DNA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DNA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL INACTIVATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL INACTIVATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL INACTIVATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LIVE ATTENUATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LIVE ATTENUATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LIVE ATTENUATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SUBUNIT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SUBUNIT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SUBUNIT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL IMMERSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL IMMERSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL IMMERSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL BATH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL BATH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL BATH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL DIP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL DIP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL DIP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL INJECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL INJECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL INJECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL FINFISH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL FINFISH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL FINFISH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CARP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CARP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CARP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CATFISH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CATFISH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CATFISH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL SALMON MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SALMON MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SALMON MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL TILAPIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL TILAPIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TILAPIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TROUT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL TROUT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TROUT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SHELLFISH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SHELLFISH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SHELLFISH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CRAB MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CRAB MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CRAB MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL MUSSEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL MUSSEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MUSSEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL OYSTER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL OYSTER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL OYSTER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL SHRIMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL SHRIMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SHRIMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CONVENTIONAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CONVENTIONAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CONVENTIONAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL NEXT GENERATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL NEXT GENERATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL NEXT GENERATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL BACTERIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL BACTERIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL BACTERIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL FUNGAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL FUNGAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL FUNGAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL PARASITIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PARASITIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PARASITIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL VIRAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL VIRAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL VIRAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL PROPHYLACTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL PROPHYLACTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL PROPHYLACTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 127. EUROPE AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. EUROPE AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 129. EUROPE AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 130. EUROPE AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 131. EUROPE AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 132. EUROPE AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 133. EUROPE AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 134. EUROPE AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 135. EUROPE AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 136. EUROPE AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. MIDDLE EAST AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 139. MIDDLE EAST AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 140. MIDDLE EAST AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 141. MIDDLE EAST AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 142. MIDDLE EAST AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 143. MIDDLE EAST AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 147. AFRICA AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. AFRICA AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 149. AFRICA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 150. AFRICA AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 151. AFRICA AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 152. AFRICA AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 153. AFRICA AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 154. AFRICA AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 155. AFRICA AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 156. AFRICA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. ASEAN AQUACULTURE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. ASEAN AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 160. ASEAN AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 161. ASEAN AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 162. ASEAN AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 163. ASEAN AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 164. ASEAN AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 165. ASEAN AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 166. ASEAN AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 167. ASEAN AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 168. GCC AQUACULTURE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. GCC AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 170. GCC AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 171. GCC AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 172. GCC AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 173. GCC AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 174. GCC AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 175. GCC AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 176. GCC AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 177. GCC AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION AQUACULTURE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. BRICS AQUACULTURE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 189. BRICS AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 190. BRICS AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 191. BRICS AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 192. BRICS AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 193. BRICS AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 194. BRICS AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 195. BRICS AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 196. BRICS AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 197. BRICS AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. G7 AQUACULTURE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 199. G7 AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 200. G7 AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 201. G7 AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 202. G7 AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 203. G7 AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 204. G7 AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 205. G7 AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 206. G7 AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 207. G7 AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. NATO AQUACULTURE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 209. NATO AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 210. NATO AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 211. NATO AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 212. NATO AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 213. NATO AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 214. NATO AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 215. NATO AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 216. NATO AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 217. NATO AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 218. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 219. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 220. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 221. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 222. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 223. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 224. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 227. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 228. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 229. CANADA AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 230. CANADA AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 231. CANADA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 232. CANADA AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 233. CANADA AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 234. CANADA AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 235. CANADA AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 236. CANADA AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 237. CANADA AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 238. CANADA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. MEXICO AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 241. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 242. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 243. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 244. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 245. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 246. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 247. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 248. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 249. BRAZIL AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 250. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 251. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 252. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 253. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 254. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 255. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 256. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 257. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 258. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 259. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 261. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 263. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 264. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 265. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 266. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. GERMANY AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 270. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 271. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 272. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 273. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 274. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 275. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 276. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 277. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 278. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. FRANCE AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 281. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 282. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 283. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 284. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 285. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 286. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 287. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 288. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 289. RUSSIA AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 290. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 291. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 292. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 293. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 294. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 295. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 296. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 299. ITALY AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. ITALY AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 301. ITALY AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 302. ITALY AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 303. ITALY AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 304. ITALY AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 305. ITALY AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 306. ITALY AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 307. ITALY AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 308. ITALY AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. SPAIN AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 310. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 311. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 312. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 313. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 314. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 315. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 316. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 317. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 318. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 319. CHINA AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. CHINA AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 321. CHINA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 322. CHINA AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 323. CHINA AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 324. CHINA AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 325. CHINA AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 326. CHINA AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 327. CHINA AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 328. CHINA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 329. INDIA AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 330. INDIA AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 331. INDIA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 332. INDIA AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 333. INDIA AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 334. INDIA AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 335. INDIA AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 336. INDIA AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 337. INDIA AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 338. INDIA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 339. JAPAN AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 340. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 341. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 342. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 343. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 344. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 345. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 346. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 347. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 348. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 349. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 350. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 351. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 352. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 353. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 354. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 355. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 356. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 357. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 358. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 359. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 360. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 361. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 362. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY IMMERSION, 2017-2032 (USD MILLION)
TABLE 363. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY TARGET SPECIES, 2017-2032 (USD MILLION)
TABLE 364. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY FINFISH, 2017-2032 (USD MILLION)
TABLE 365. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY SHELLFISH, 2017-2032 (USD MILLION)
TABLE 366. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 367. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY PATHOGEN TYPE, 2017-2032 (USD MILLION)
TABLE 368. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY

Companies Mentioned

  • Benchmark Holdings plc
  • Bio Angle Vacs Sdn Bhd
  • Ceva Sante Animale
  • Hester Biosciences Limited
  • HIPRA S A
  • Ictyogroup
  • Indian Immunologicals Ltd
  • KBNP Inc
  • Kyoto Biken Laboratories Inc
  • Merck & Co Inc
  • Nisseiken Co Ltd
  • Phibro Animal Health Corporation
  • Tecnovax S A
  • Vaxxinova International B V by EW Group
  • Veterquimica S A
  • Virbac S A
  • Zoetis Inc

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 410.74 Million
Forecasted Market Value ( USD ) by 2032 $ 547.65 Million
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Aquaculture Vaccines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Aquaculture Vaccines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 134 Pages
  • Global
From
Aquaculture Vaccines Market Size, Share & Trends Analysis Report by Product, Route of Administration, Application, Distribution Channel, Region, and Growth Forecasts, 2026-2033 - Product Image

Aquaculture Vaccines Market Size, Share & Trends Analysis Report by Product, Route of Administration, Application, Distribution Channel, Region, and Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Commercial Aquaculture Vaccines Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Commercial Aquaculture Vaccines Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 194 Pages
  • Global
From
Aquaculture Vaccines Market Outlook 2026-2034: Market Share, and Growth Analysis by Vaccine Type, Species, Application, End User - Product Image

Aquaculture Vaccines Market Outlook 2026-2034: Market Share, and Growth Analysis by Vaccine Type, Species, Application, End User

  • Report
  • 160 Pages
  • Global
From
Aquaculture Therapeutics Market - Global Forecast 2026-2032 - Product Image

Aquaculture Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From

About the Aquaculture Vaccine Market

The Aquaculture Vaccine market is a segment of the Animal Healthcare/Veterinary industry that focuses on the development and production of vaccines for aquatic species. Vaccines are used to protect fish, crustaceans, and mollusks from diseases caused by bacteria, viruses, fungi, and parasites. Vaccines are administered through injection, immersion, or oral delivery. The Aquaculture Vaccine market is driven by the increasing demand for seafood, the growing awareness of animal welfare, and the need to protect aquatic species from disease. The market is also driven by advances in vaccine technology, such as the development of recombinant vaccines and the use of adjuvants. Some companies in the Aquaculture Vaccine market include AquaVax, AquaHealth, AquaVet, AquaPharm, and AquaVet Pharma. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.